Avrobio Inc Reports Results For The Quarter Ended In March: Earnings Summary

Tectonic Therapeutic

11/05/2023 13:19

* AVROBIO Inc  AVRO.OQ  reported a quarterly adjusted loss
of 57
cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for a loss
of 55 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * AVROBIO Inc's reported EPS for the quarter was a loss
of 57
cents​.
    * The mean earnings estimate of analysts had fallen by
about 25.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AVROBIO Inc shares had fallen by 32.8% this quarter and
lost 5.7% so far this year.
    * The company reported a quarterly loss of $24.96 million.
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 12:19 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.54          -0.57          Missed
 Dec. 31 2022      -0.49          -0.57          Missed
 Sep. 30 2022      -0.55          -0.52          Beat
 Jun. 30 2022      -0.57          -0.64          Missed